LifeStance Health Group, Inc.
LFST
$7.59
-$0.29-3.68%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 18.50% | 20.08% | 20.56% | 21.39% | 22.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.50% | 20.08% | 20.56% | 21.39% | 22.82% |
| Cost of Revenue | 12.61% | 14.78% | 15.96% | 18.23% | 21.05% |
| Gross Profit | 33.20% | 33.68% | 32.57% | 29.63% | 27.46% |
| SG&A Expenses | 4.06% | 0.47% | 0.83% | -0.89% | -6.89% |
| Depreciation & Amortization | -11.79% | 1.80% | 10.13% | 15.64% | 16.24% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.43% | 9.55% | 10.85% | 11.79% | 10.94% |
| Operating Income | 75.90% | 62.61% | 48.11% | 37.98% | 38.69% |
| Income Before Tax | 72.11% | 60.78% | 14.27% | 6.42% | 11.23% |
| Income Tax Expenses | 99.16% | 124.21% | 60.34% | -9.60% | -18.38% |
| Earnings from Continuing Operations | 69.16% | 49.30% | 8.11% | 7.66% | 13.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 69.16% | 49.30% | 8.11% | 7.66% | 13.59% |
| EBIT | 75.90% | 62.61% | 48.11% | 37.98% | 38.69% |
| EBITDA | 188.95% | 134.11% | 101.28% | 75.86% | 66.56% |
| EPS Basic | 70.11% | 50.55% | 11.41% | 10.90% | 16.63% |
| Normalized Basic EPS | 62.48% | 55.20% | 43.28% | 35.82% | 36.79% |
| EPS Diluted | 70.11% | 50.55% | 11.41% | 10.90% | 16.63% |
| Normalized Diluted EPS | 62.48% | 55.20% | 43.28% | 35.82% | 36.79% |
| Average Basic Shares Outstanding | 3.59% | 3.56% | 4.09% | 3.64% | 3.29% |
| Average Diluted Shares Outstanding | 3.59% | 3.56% | 4.09% | 3.64% | 3.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
